- What is new in the world of basal insulins?2014 | Second Faculty of Medicine
- Less discussed aspects in the choice of basal insulin2021 | Second Faculty of Medicine
- Clinical efficacy and safety of basal insulin analogue glargine in patients with type 2 diabetes mellitus2016 | First Faculty of Medicine
- Addition of Basal Insulin to Oral Antidiabetic Agents in Patients with Inadequately Controlled Type 2 Diabetes Leads to Improved HbA1c Levels: Metabolic Control, Frequency of Hypoglycemia, and Insulin Titration Analysis as Results of a Prospective Observational Study (BALI Study)2019 | Second Faculty of Medicine
- Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 52016 | Publication without faculty affiliation
- Six-month experience with the basal insulin analogue detemir2006 | Faculty of Medicine in Pilsen
- Treatment with the combination of basal insulin and incretin therapy2012 | Second Faculty of Medicine
- Insulin glargine: a proven basal insulin analogue2014 | Second Faculty of Medicine
- The phenomenon of fasting hyperglycemia and its possible influence of new basal insulins2015 | First Faculty of Medicine
- Self-titration of basal insulin glargine in type 2. diabetes mellitus patient2007 | Central Library of Charles University, Third Faculty of Medicine
- How a patient can benefit from adding basal insulin to GLP-1RA therapy2023 | Publication without faculty affiliation
- Pitfalls of the treatment with basal insulin - practical limitations of the adjustment of insulin dose based on fasting glycemia2011 | Second Faculty of Medicine
- Insulin glargine 300 U/ml (Toujeo) - an optimal basal insulin for a geriatric patient treated for type 1 diabetes mellitus2018 | Second Faculty of Medicine
- Insulin Glargine 300 Units/mL Effectiveness in Patients with T2DM Uncontrolled by Basal Insulin in Real-Life Settings in the Czech Republic2020 | First Faculty of Medicine
- Effect of the use of lixisenatide in antidiabetic therapy intensification2015 | First Faculty of Medicine
- Efficacy of insulin glargine 300 U/ml in patients with type 2 diabetes insufficiently compensated by basal insulin therapy in the conditions of routine clinical practice in the Czech Republic2021 | First Faculty of Medicine
- Dose adjustment of insulin according to fasting blood glucose - myths, mistakes, the truth for the treatment of basal insulin2011 | Second Faculty of Medicine
- The influence of the change of basal insulin on body weight in an obese patient with type 1 diabetes mellitus2008 | Second Faculty of Medicine
- Long-term Improvement of Fasting Glycaemia after Switching Basal Insulin from NPH to Determir in Children with Type 1 Diabetes: A 1-Year Multicentre Study2008 | Second Faculty of Medicine
- Dawn phenomenon2017 | Second Faculty of Medicine
- Basal insulin glargine using a basal-bolus regimen in a common clinical practice: observational, non-interventional, multicenter, national project LINDA (Lantus in daily practice - safety and efficacy in basal bolus regimen)2014 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Adherence of type 2 dibetes patients on insulin analogues application: missed dose, time inmprecision and dose reduction2014 | First Faculty of Medicine
- Kontinuální monitorování koncentrace glukózy u pacientů s diabetem 2. typu starších 65 let léčených bazálním inzulinem2022 | First Faculty of Medicine
- Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results2022 | First Faculty of Medicine
- Do diabetologists choose a therapy rationally? Basic results of the PROROK project (A prospective observation project to assess the relevance of the difference between fasting glycemia and postprandial glycemia to estimation of success of type 2 diabetes therapy)2015 | Second Faculty of Medicine
- PROROK project results after 6 months of intervention (Prospective observation project focusing on the relevance of the difference between fasting blood glucose levels and postprandial blood glucose for estimation of success of type 2 diabetes therapy)2015 | Second Faculty of Medicine
- Bariéry účinné titrace bazálního inzulinu u diabetiků 2. typu2018 | Second Faculty of Medicine
- Mild hypoglycaemia is common in type 2 diabetic patients treated with insulin analogues in the Czech Republic and the patients are concerned about it: results of a GAPP2TM survey (Global Attitudes of Physicians and Patient)2015 | First Faculty of Medicine
- Results of Insulin Therapy in Type 2 Diabetes Mellitus Patients in the Czech Republic: Do They Reflect the Current Status in Other Countries?2019 | Third Faculty of Medicine, Second Faculty of Medicine
- An update on the safety of insulin-GLP-1 receptor agonist combinations in type 2 diabetes mellitus2022 | First Faculty of Medicine